EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

White matter hyperintensities are higher among early‐onset Alzheimer's disease participants than their cognitively normal and early‐onset nonAD peers: Longitudinal Early‐onset Alzheimer's Disease Study (LEADS)

Ani Eloyan, Maryanne Thangarajah, Na An, Bret J Borowski, Ashritha L Reddy, Paul Aisen, Jeffrey L Dage, Tatiana Foroud, Bernardino Ghetti, Percy Griffin, Dustin Hammers, Leonardo Iaccarino and 38 more

Alzheimer's & Dementia · 2023-11 · 19 (S9)

DOI: 10.1002/alz.13402 ↗

At a glance

Übersichtsarbeit in Alzheimer's & Dementia, published online on 2023-07-25. Written by Ani Eloyan and 49 co-authors. Institution: Department of Biostatistics, Center for Statistical Sciences, Brown University, Providence, Rhode Island, USA. Major MEDLINE topics: Alzheimer Disease, White Matter, Cognitive Dysfunction. Cited 18 times so far (Crossref); 17 references. The full text is freely available in PubMed Central. Funded by: NIA NIH HHS, Alzheimer's Association, NIDCD NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

INTRODUCTION We compared white matter hyperintensities (WMHs) in early‐onset Alzheimer's disease (EOAD) with cognitively normal (CN) and early‐onset amyloid‐negative cognitively impaired (EOnonAD) groups in the Longitudinal Early‐Onset Alzheimer's Disease Study. METHODS We investigated the role of increased WMH in cognition and amyloid and tau burden. We compared WMH burden of 205 EOAD, 68 EOnonAD, and 89 CN participants in lobar regions using t ‐tests and analyses of covariance. Linear regression analyses were used to investigate the association between WMH and cognitive impairment and that between amyloid and tau burden. RESULTS EOAD showed greater WMHs compared with CN and EOnonAD participants across all regions with no significant differences between CN and EOnonAD groups. Greater WMHs were associated with worse cognition. Tau burden was positively associated with WMH burden in the EOAD group. DISCUSSION EOAD consistently showed higher WMH volumes. Overall, greater WMHs were associated with worse cognition and higher tau burden in EOAD. Highlights This study represents a comprehensive characterization of WMHs in sporadic EOAD. WMH volumes are associated with tau burden from positron emission tomography (PET) in EOAD, suggesting WMHs are correlated with increasing burden of AD. Greater WMH volumes are associated with worse performance on global cognitive tests. EOAD participants have higher WMH volumes compared with CN and early‐onset amyloid‐negative cognitively impaired (EOnonAD) groups across all brain regions.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseWhite MatterCognitive DysfunctionHumansAmyloid beta-Peptidestau ProteinsMagnetic Resonance ImagingAmyloidogenic ProteinsAmyloid

Author keywords

Alzheimer's diseaseEOADWMHamyloidtau PETtau positron emission tomographywhite matter hyperintensities

Substances

Amyloid beta-Peptidestau ProteinsAmyloidogenic ProteinsAmyloid

Authors and institutions

  • Department of Biostatistics, Center for Statistical Sciences, Brown University, Providence, Rhode Island, USA.
  • Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA.
  • Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Pathology & Laboratory Medicine Indiana University School of Medicine, Indianapolis, Indiana, USA.

Funding

  • NIA NIH HHS
  • Alzheimer's Association
  • NIDCD NIH HHS

Cite

APA

Eloyan, A., Thangarajah, M., An, N., Borowski, B. J., Reddy, A. L., Aisen, P., Dage, J. L., Foroud, T., Ghetti, B., Griffin, P., Hammers, D., Iaccarino, L., Jack, C. R., Kirby, K., Kramer, J., Koeppe, R., Kukull, W. A., La Joie, R., Mundada, N. S., …, & LEADS Consortium (2023). White matter hyperintensities are higher among early‐onset Alzheimer's disease participants than their cognitively normal and early‐onset nonAD peers: Longitudinal Early‐onset Alzheimer's Disease Study (LEADS). Alzheimer's & Dementia, 19(S9). https://doi.org/10.1002/alz.13402

Vancouver

Eloyan A, Thangarajah M, An N, Borowski BJ, Reddy AL, Aisen P, et al. White matter hyperintensities are higher among early‐onset Alzheimer's disease participants than their cognitively normal and early‐onset nonAD peers: Longitudinal Early‐onset Alzheimer's Disease Study (LEADS). Alzheimer's & Dementia. 2023;19(S9). doi:10.1002/alz.13402

BibTeX
@article{Eloyan2023,
  author = {Eloyan, Ani and Thangarajah, Maryanne and An, Na and Borowski, Bret J and Reddy, Ashritha L and Aisen, Paul and Dage, Jeffrey L and Foroud, Tatiana and Ghetti, Bernardino and Griffin, Percy and Hammers, Dustin and Iaccarino, Leonardo and Jack, Clifford R and Kirby, Kala and Kramer, Joel and Koeppe, Robert and Kukull, Walter A and La Joie, Renaud and Mundada, Nidhi S and Murray, Melissa E and Nudelman, Kelly and Rumbaugh, Malia and Soleimani-Meigooni, David N and Toga, Arthur and Touroutoglou, Alexandra and Atri, Alireza and Day, Gregory S and Duara, Ranjan and Graff-Radford, Neill R and Honig, Lawrence S and Jones, David T and Masdeu, Joseph and Mendez, Mario F and Musiek, Erik and Onyike, Chiadi U and Rogalski, Emily and Salloway, Stephen and Sha, Sharon and Turner, Raymond S and Wingo, Thomas S and Wolk, David A and Womack, Kyle and Beckett, Laurel and Gao, Sujuan and Carrillo, Maria C and Rabinovici, Gil and Apostolova, Liana G and Dickerson, Brad and Vemuri, Prashanthi and LEADS Consortium, LEADS Consortium},
  title = {White matter hyperintensities are higher among early‐onset Alzheimer's disease participants than their cognitively normal and early‐onset nonAD peers: Longitudinal Early‐onset Alzheimer's Disease Study (LEADS)},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {S9},
  doi = {10.1002/alz.13402}
}
Start for free →